• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ORM1 通过 CALR 介导线粒体凋亡促进肾透明细胞肾细胞癌 (KIRC) 的肿瘤进展。

ORM1 promotes tumor progression of kidney renal clear cell carcinoma (KIRC) through CALR-mediated apoptosis.

机构信息

Department of Nephrology, The Sixth People's Hospital Affiliated to Shanghai Jiaotong University, Shanghai, 200233, China.

Physical Examination Center, Shanghai Lung Hospital Affiliated to Tongji University, Shanghai, 200433, China.

出版信息

Sci Rep. 2023 Sep 21;13(1):15687. doi: 10.1038/s41598-023-42962-w.

DOI:10.1038/s41598-023-42962-w
PMID:37735575
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10514263/
Abstract

Kidney renal clear cell carcinoma (KIRC) is the most prevalent type of kidney cancer and causes thousands of deaths each year. The prognosis for KIRC is poor. One critical factor is that the mechanism beneath KIRC is unclear. ORM1 is a reactant to acute inflammation. In this study, we demonstrated that methylation of ORM1 promoter was low and ORM1 was expressed significantly higher in KIRC. KIRC with higher ORM1 expression exhibited worse survival probability. Meanwhile, ORM1 was expressed higher in KIRC cell lines. When ORM1 was knocked down, cell proliferation ability was inhibited potently compared to the NC control. Cell migration as well as invasion ability were also suppressed dramatically. At molecular level, the expression of active caspase-3 and Bax was upregulated in ORM1-KD group while Bcl-2 downregulated. Moreover, CALR decreased following ORM1-KD and rescued expression of CALR increased Bcl-2 level but reduced the level of cleaved caspase-3 and Bax. Consistently, the apoptotic rate of 786-O and Caki-2 cells was upregulated in ORM1-KD but downregulated after CALR overexpression. The activity of caspase-3 was also regulated by ORM1-KD. In addition, the inhibition rate of sorafenib was enhanced in ORM1 KD group but reduced after overexpression of ORM1. Conclusively, ORM1 is clinically associated with progression of KIRC and regulates cell proliferation, migration, invasion, and apoptosis in KIRC. Moreover, ORM1 affects the efficiency of sorafenib in KIRC and regulates caspase-3 mediated cascades response through CALR molecule. This study provides us a new way to recognize the development and progression in KIRC.

摘要

肾透明细胞癌(KIRC)是最常见的肾癌类型,每年导致数千人死亡。KIRC 的预后较差。一个关键因素是 KIRC 背后的机制尚不清楚。ORM1 是急性炎症的反应物。在本研究中,我们证明了 ORM1 启动子的甲基化水平较低,KIRC 中 ORM1 的表达明显更高。ORM1 表达较高的 KIRC 表现出更差的生存概率。同时,KIRC 细胞系中 ORM1 的表达更高。当 ORM1 被敲低时,与 NC 对照相比,细胞增殖能力被强烈抑制。细胞迁移和侵袭能力也被显著抑制。在分子水平上,ORM1-KD 组中活性 caspase-3 和 Bax 的表达上调,而 Bcl-2 下调。此外,CALR 减少后,ORM1-KD 表达增加,CALR 增加 Bcl-2 水平,但降低 cleaved caspase-3 和 Bax 水平。此外,786-O 和 Caki-2 细胞的凋亡率在 ORM1-KD 中上调,但在 CALR 过表达后下调。ORM1-KD 还调节 caspase-3 的活性。此外,ORM1-KD 组中索拉非尼的抑制率增强,但 ORM1 过表达后降低。总之,ORM1 与 KIRC 的进展相关,并调节 KIRC 中的细胞增殖、迁移、侵袭和凋亡。此外,ORM1 通过 CALR 分子影响 KIRC 中索拉非尼的效率,并调节 caspase-3 介导的级联反应。本研究为我们提供了一种新的方法来认识 KIRC 的发展和进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3120/10514263/b0e8f10c8d9f/41598_2023_42962_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3120/10514263/ba35b8616b2c/41598_2023_42962_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3120/10514263/55c27b92112d/41598_2023_42962_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3120/10514263/dd8af83fb160/41598_2023_42962_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3120/10514263/d500952c3fa0/41598_2023_42962_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3120/10514263/a007a9b33dc9/41598_2023_42962_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3120/10514263/b0e8f10c8d9f/41598_2023_42962_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3120/10514263/ba35b8616b2c/41598_2023_42962_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3120/10514263/55c27b92112d/41598_2023_42962_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3120/10514263/dd8af83fb160/41598_2023_42962_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3120/10514263/d500952c3fa0/41598_2023_42962_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3120/10514263/a007a9b33dc9/41598_2023_42962_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3120/10514263/b0e8f10c8d9f/41598_2023_42962_Fig6_HTML.jpg

相似文献

1
ORM1 promotes tumor progression of kidney renal clear cell carcinoma (KIRC) through CALR-mediated apoptosis.ORM1 通过 CALR 介导线粒体凋亡促进肾透明细胞肾细胞癌 (KIRC) 的肿瘤进展。
Sci Rep. 2023 Sep 21;13(1):15687. doi: 10.1038/s41598-023-42962-w.
2
zDHHC3-mediated S-palmitoylation of SLC9A2 regulates apoptosis in kidney clear cell carcinoma.zDHHC3介导的SLC9A2的S-棕榈酰化调控肾透明细胞癌中的细胞凋亡。
J Cancer Res Clin Oncol. 2024 Apr 15;150(4):194. doi: 10.1007/s00432-024-05737-y.
3
NR1B2 suppress kidney renal clear cell carcinoma (KIRC) progression by regulation of LATS 1/2-YAP signaling.NR1B2 通过调控 LATS1/2-YAP 信号抑制肾透明细胞癌(KIRC)的进展。
J Exp Clin Cancer Res. 2019 Aug 7;38(1):343. doi: 10.1186/s13046-019-1344-3.
4
LncRNA MALAT1 modified progression of clear cell kidney carcinoma (KIRC) by regulation of miR-194-5p/ACVR2B signaling.长链非编码 RNA MALAT1 通过调节 miR-194-5p/ACVR2B 信号通路来改变肾透明细胞癌(KIRC)的进展。
Mol Carcinog. 2019 Feb;58(2):279-292. doi: 10.1002/mc.22926. Epub 2018 Oct 31.
5
Comprehensive analysis of the HOXA gene family identifies HOXA13 as a novel oncogenic gene in kidney renal clear cell carcinoma.全面分析 HOXA 基因家族发现 HOXA13 是肾透明细胞癌中的一个新的致癌基因。
J Cancer Res Clin Oncol. 2020 Aug;146(8):1993-2006. doi: 10.1007/s00432-020-03259-x. Epub 2020 May 22.
6
PGK1 contributes to tumorigenesis and sorafenib resistance of renal clear cell carcinoma via activating CXCR4/ERK signaling pathway and accelerating glycolysis.PGK1 通过激活 CXCR4/ERK 信号通路和加速糖酵解促进肾透明细胞癌的发生和索拉非尼耐药。
Cell Death Dis. 2022 Feb 4;13(2):118. doi: 10.1038/s41419-022-04576-4.
7
OCLN as a novel biomarker for prognosis and immune infiltrates in kidney renal clear cell carcinoma: an integrative computational and experimental characterization.OCLN 作为肾透明细胞癌预后和免疫浸润的新型生物标志物:综合计算和实验特征分析。
Front Immunol. 2023 Sep 22;14:1224904. doi: 10.3389/fimmu.2023.1224904. eCollection 2023.
8
Bioinformatics Prediction and Experimental Verification Identify CAB39L as a Diagnostic and Prognostic Biomarker of Kidney Renal Clear Cell Carcinoma.生物信息学预测和实验验证确定 CAB39L 为肾透明细胞癌的诊断和预后生物标志物。
Medicina (Kaunas). 2023 Apr 6;59(4):716. doi: 10.3390/medicina59040716.
9
Downregulation of RAB17 have a poor prognosis in kidney renal clear cell carcinoma and its expression correlates with DNA methylation and immune infiltration.RAB17 的下调与肾透明细胞癌的不良预后相关,其表达与 DNA 甲基化和免疫浸润有关。
Cell Signal. 2023 Sep;109:110743. doi: 10.1016/j.cellsig.2023.110743. Epub 2023 Jun 1.
10
TROAP Promotes the Proliferation, Migration, and Metastasis of Kidney Renal Clear Cell Carcinoma with the Help of STAT3.TROAP 通过帮助 STAT3 促进肾透明细胞癌的增殖、迁移和转移。
Int J Mol Sci. 2023 Jun 2;24(11):9658. doi: 10.3390/ijms24119658.

引用本文的文献

1
S100P is a core gene for diagnosing and predicting the prognosis of sepsis.S100P是用于诊断和预测脓毒症预后的核心基因。
Sci Rep. 2025 Feb 25;15(1):6718. doi: 10.1038/s41598-025-90858-8.
2
Orosomucoid 1 interacts with S100A12 and activates ERK signalling to expedite the advancement of bladder cancer.类粘蛋白1与S100A12相互作用并激活ERK信号传导,以加速膀胱癌的进展。
Cell Adh Migr. 2025 Dec;19(1):1-11. doi: 10.1080/19336918.2024.2434209. Epub 2024 Dec 7.
3
Influence of Microenvironmental Orchestration on Multicellular Lung Alveolar Organoid Development from Human Induced Pluripotent Stem Cells.

本文引用的文献

1
RCN2 promotes Nasopharyngeal carcinoma progression by curbing Calcium flow and Mitochondrial apoptosis.RCN2 通过抑制钙离子流动和线粒体凋亡促进鼻咽癌的进展。
Cell Oncol (Dordr). 2023 Aug;46(4):1031-1048. doi: 10.1007/s13402-023-00796-8. Epub 2023 Mar 23.
2
A large-scale targeted proteomics of plasma extracellular vesicles shows utility for prognosis prediction subtyping in colorectal cancer.大规模靶向蛋白质组学分析血浆细胞外囊泡可用于结直肠癌的预后预测亚型分析。
Cancer Med. 2023 Mar;12(6):7616-7626. doi: 10.1002/cam4.5442. Epub 2022 Nov 16.
3
Renal cell carcinoma: an overview of the epidemiology, diagnosis, and treatment.
微环境编排对人诱导多能干细胞来源的多细胞肺肺泡类器官发育的影响
Stem Cell Rev Rep. 2025 Jan;21(1):254-275. doi: 10.1007/s12015-024-10789-1. Epub 2024 Oct 17.
4
Identification and clinical validation of the role of anoikis-related genes in diabetic foot.失巢凋亡相关基因在糖尿病足中作用的鉴定及临床验证
Int Wound J. 2024 Mar;21(3):e14771. doi: 10.1111/iwj.14771.
肾细胞癌:流行病学、诊断和治疗概述。
G Ital Nefrol. 2022 Jun 20;39(3):2022-vol3.
4
ORM 1 as a biomarker of increased vascular invasion and decreased sorafenib sensitivity in hepatocellular carcinoma.ORMDL3 作为肝癌血管侵犯增加和索拉非尼敏感性降低的生物标志物。
Bosn J Basic Med Sci. 2022 Oct 23;22(6):949-958. doi: 10.17305/bjbms.2022.7268.
5
Identification of Potential Predictor of Biochemical Recurrence in Prostate Cancer.前列腺癌生化复发潜在预测指标的鉴定
Int J Gen Med. 2022 May 12;15:4897-4905. doi: 10.2147/IJGM.S355435. eCollection 2022.
6
Characterization of alpha-1-acid glycoprotein as a potential biomarker for breast cancer.鉴定α-1-酸性糖蛋白作为乳腺癌潜在生物标志物。
Bioengineered. 2022 Mar;13(3):5818-5826. doi: 10.1080/21655979.2022.2036303.
7
Hallmarks of Cancer: New Dimensions.癌症的特征:新视角。
Cancer Discov. 2022 Jan;12(1):31-46. doi: 10.1158/2159-8290.CD-21-1059.
8
Cancer statistics, 2022.癌症统计数据,2022 年。
CA Cancer J Clin. 2022 Jan;72(1):7-33. doi: 10.3322/caac.21708. Epub 2022 Jan 12.
9
DNA Methylation Profiling: An Emerging Paradigm for Cancer Diagnosis.DNA 甲基化分析:癌症诊断的新兴范例。
Annu Rev Pathol. 2022 Jan 24;17:295-321. doi: 10.1146/annurev-pathol-042220-022304. Epub 2021 Nov 4.
10
Comparison of orosomucoid-1 immunoexpression and angiogenesis between oral squamous cell carcinoma cases with different histological grades.不同组织学分级的口腔鳞状细胞癌病例中类粘蛋白-1免疫表达与血管生成的比较。
J Oral Maxillofac Pathol. 2021 May-Aug;25(2):368. doi: 10.4103/0973-029X.325243. Epub 2021 Aug 31.